HL Financial Services LLC boosted its holdings in shares of Johnson & Johnson (NYSE:JNJ) by 0.6% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,552,187 shares of the company’s stock after acquiring an additional 9,065 shares during the period. Johnson & Johnson comprises 3.5% of HL Financial Services LLC’s portfolio, making the stock its 6th largest holding. HL Financial Services LLC owned approximately 0.06% of Johnson & Johnson worth $198,913,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also made changes to their positions in the company. Enterprise Financial Services Corp raised its position in shares of Johnson & Johnson by 2.4% in the fourth quarter. Enterprise Financial Services Corp now owns 15,075 shares of the company’s stock valued at $2,106,000 after buying an additional 358 shares during the last quarter. Welch Investments LLC grew its holdings in Johnson & Johnson by 1.0% in the fourth quarter. Welch Investments LLC now owns 35,981 shares of the company’s stock valued at $5,027,000 after purchasing an additional 373 shares during the period. YHB Investment Advisors Inc. grew its holdings in Johnson & Johnson by 0.5% in the fourth quarter. YHB Investment Advisors Inc. now owns 76,534 shares of the company’s stock valued at $10,693,000 after purchasing an additional 381 shares during the period. Franklin Parlapiano Turner & Welch LLC grew its holdings in Johnson & Johnson by 1.0% in the fourth quarter. Franklin Parlapiano Turner & Welch LLC now owns 38,387 shares of the company’s stock valued at $5,363,000 after purchasing an additional 382 shares during the period. Finally, Regent Investment Management LLC grew its holdings in Johnson & Johnson by 0.8% in the fourth quarter. Regent Investment Management LLC now owns 47,171 shares of the company’s stock valued at $6,591,000 after purchasing an additional 385 shares during the period. Institutional investors own 65.96% of the company’s stock.
Top 5 Value Stocks To Own Right Now: iShares Mortgage Real Estate Capped (REM)
Advisors’ Opinion:
- [By Stephan Byrd]
Remme (CURRENCY:REM) traded up 1.2% against the US dollar during the 24-hour period ending at 14:00 PM E.T. on August 19th. Remme has a total market capitalization of $4.41 million and approximately $486,178.00 worth of Remme was traded on exchanges in the last day. One Remme token can now be bought for $0.0073 or 0.00000115 BTC on major cryptocurrency exchanges including Tidex, IDEX, DEx.top and Kuna. Over the last week, Remme has traded 15.2% lower against the US dollar.
- [By Stephan Byrd]
Remme (REM) is a token. It launched on December 4th, 2017. Remme’s total supply is 1,000,000,000 tokens and its circulating supply is 614,315,410 tokens. Remme’s official Twitter account is @remme_io and its Facebook page is accessible here. The Reddit community for Remme is /r/remme and the currency’s Github account can be viewed here. The official website for Remme is remme.io. The official message board for Remme is medium.com/remme.
- [By Ethan Ryder]
Remme (CURRENCY:REM) traded 1.4% higher against the U.S. dollar during the twenty-four hour period ending at 22:00 PM E.T. on August 31st. Remme has a market cap of $4.00 million and $344,172.00 worth of Remme was traded on exchanges in the last 24 hours. One Remme token can now be bought for $0.0066 or 0.00000094 BTC on major exchanges including Tidex, Kuna, DEx.top and Gate.io. During the last seven days, Remme has traded up 7.7% against the U.S. dollar.
- [By Shane Hupp]
Stifel Financial Corp decreased its stake in iShares FTSE NAREIT Mortg.REITIn Fd (BMV:REM) by 57.3% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 9,921 shares of the company’s stock after selling 13,308 shares during the quarter. Stifel Financial Corp’s holdings in iShares FTSE NAREIT Mortg.REITIn Fd were worth $422,000 at the end of the most recent quarter.
Top 5 Value Stocks To Own Right Now: Match Group, Inc.(MTCH)
Advisors’ Opinion:
- [By Chris Lange]
Match Group Inc. (NASDAQ: MTCH) saw its short interest decrease slightly to 24.28 million from the previous 24.74 million. Shares were trading at $55.46, in a 52-week range of $24.40 to $60.95.
- [By Motley Fool Staff]
Match Group (NASDAQ:MTCH) Q1 2018 Earnings Conference CallMay. 9, 2018 8:30 a.m. ET
Contents:
Prepared Remarks Questions and Answers Call Participants
Prepared Remarks:
Operator
- [By Motley Fool Staff]
In this segment from MarketFoolery, host Chris Hill and analysts David Kretzmann and Aaron Bush check out the latest results from Match Group (NASDAQ:MTCH). The company behind dating sites like OkCupid, PlentyOfFish and Tinder delivered some mighty pretty growth: revenue up 36%, subscriber counts up 27%, and margins grew as well. How is it making such progress in a business where succeeding too well for your customers means they’ll leave you?
Top 5 Value Stocks To Own Right Now: Kitov Pharamceuticals Holdings Ltd.(KTOV)
Advisors’ Opinion:
- [By Lisa Levin]
Kitov Pharma Ltd (NASDAQ: KTOV) shares dropped 14 percent to $2.6000. Kitov Pharma priced its 3.26 million ADS offering at $2.50 per ADS.
Shares of Ambow Education Holding Ltd. (NASDAQ: AMBO) were down 25 percent to $4.26.
- [By Shane Hupp]
Ardelyx (NASDAQ: ARDX) and KITOV PHARMA LT/S (NASDAQ:KTOV) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, earnings, institutional ownership and dividends.
- [By Lisa Levin]
Kitov Pharma Ltd (NASDAQ: KTOV) shares dropped 16 percent to $2.56. Kitov Pharma priced its 3.26 million ADS offering at $2.50 per ADS.
Shares of Ambow Education Holding Ltd. (NASDAQ: GLNG) were down 28 percent to $4.10.
- [By Lisa Levin] Gainers
TransEnterix, Inc. (NYSE: TRXC) rose 28.8 percent to $4.03 in pre-market trading after the company disclosed that it has received the FDA clearance for expanded indications for its Senhance Surgical System.
Global Eagle Entertainment Inc. (NASDAQ: ENT) rose 15.6 percent to $2.30 in pre-market trading.
Companhia Brasileira de Distribuição (NYSE: CBD) rose 13.2 percent to $24.20 in pre-market trading.
ZTO Express (Cayman) Inc. (NYSE: ZTO) rose 12.2 percent to $21.65 in pre-market trading. Alibaba and Cainiao agreed to make strategic investment in ZTO Express of $1.38 billion.
DHI Group, Inc. (NYSE: DHX) rose 10.8 percent to $2.05 in pre-market trading.
Momo Inc. (NASDAQ: MOMO) shares rose 9.6 percent to $42.68 in pre-market trading after the company reported better-than-expected results for its first quarter and issued strong sales forecast for the second quarter.
Xenon Pharmaceuticals Inc. (NASDAQ: XENE) shares rose 9.1 percent to $6.00 in pre-market trading.
Universal Display Corporation (NASDAQ: OLED) rose 8.4 percent to $108.00 in pre-market trading.
Jupai Holdings Limited (NYSE: JP) shares rose 7 percent to $24.50 in pre-market trading after reporting Q1 results.
Net 1 UEPS Technologies, Inc. (NASDAQ: UEPS) rose 5.9 percent to $10.61 in pre-market trading.
Frontline Ltd. (NYSE: FRO) rose 5.9 percent to $5.04 in pre-market trading.
Evogene Ltd. (NASDAQ: EVGN) rose 5.5 percent to $3.27 in pre-market trading after reporting Q1 results.
Sears Holdings Corporation (NASDAQ: SHLD) rose 5.5 percent to $3.68 in pre-market trading after gaining 5.44 percent on Friday.
Kitov Pharma Ltd (NASDAQ: KTOV) shares rose 5.4 percent to $2.16 in pre-market trading.
Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.
- [By Lisa Levin]
Kitov Pharma Ltd (NASDAQ: KTOV) shares dropped 17 percent to $2.53. Kitov Pharma priced its 3.26 million ADS offering at $2.50 per ADS.
Shares of Ambow Education Holding Ltd. (NASDAQ: AMBO) were down 26 percent to $4.1999.
- [By Lisa Levin] Gainers
Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares surged 144.96 percent to close at $265.61 on Thursday in reaction to an encouraging Phase 2 clinical trial update. The clinical-stage biopharmaceutical company said its liver-directed, thyroid hormone receptor called MGL-3196 showed a statistical significance in the primary endpoint of lowering liver fat at 12 weeks and also 36 weeks.
Viking Therapeutics, Inc. (NASDAQ: VKTX) shares rose 101.01 percent to close at $9.99 on Thursday after falling 4.42 percent on Wednesday.
Akers Biosciences, Inc. (NASDAQ: AKER) jumped 45.58 percent to close at $0.474. The developer of rapid health information technologies said Wednesday afternoon it was granted a 180-day extension from the Nasdaq Stock Market to meet the requirement of a minimum $1.00 per share closing bid price for 10 straight days.
Kitov Pharma Ltd (NASDAQ: KTOV) gained 40.93 percent to close at $3.03 after the FDA approved Kitov's Consensi for the treatment of osteoarthritis pain and hypertension.
China Customer Relations Centers, Inc. (NASDAQ: CCRC) rose 28.21 percent to close at $19.86.
J.Jill, Inc. (NYSE: JILL) climbed 26.45 percent to close at $7.84 after the company posted upbeat quarterly earnings.
Curis, Inc. (NASDAQ: CRIS) shares climbed 21.93 percent to close at $2.78 in reaction to an encouraging FDA update. The biotechnology company that focuses on therapies for the treatment of cancer said the FDA granted a Fast Track designation for fimepinostat (CUDC-907) in patients with relapsed or refractory.
Boxlight Corporation (NASDAQ: BOXL) gained 21.23 percent to close at $7.48.
Kirkland's, Inc. (NASDAQ: KIRK) rose 16.21 percent to close at $12.83 after reporting upbeat Q1 results.
The Brink's Company (NYSE: BCO) jumped 16.2 percent to close at $79.25 as the company announced plans to acquire Dunbar Armored for $520 million in cash.
Applied Optoelectronics, Inc. (NASDAQ: AAOI) rose 15.14 percent to c
Top 5 Value Stocks To Own Right Now: trivago N.V. (TRVG)
Advisors’ Opinion:
- [By Motley Fool Transcribing]
Trivago (NASDAQ:TRVG) Q4 2018 Earnings Conference CallFeb. 6, 2019 8:00 a.m. ET
Contents:
Prepared Remarks Questions and Answers Call Participants
Prepared Remarks:Operator
- [By Paul Ausick]
Trivago NV (NASDAQ: TRVG) dropped about 5% Thursday to post a new 52-week low of $6.17. Shares closed at $6.50 on Wednesday and the stock’s 52-week high is $24.27. Volume was nearly double the daily average of around 1.1 million shares. The company had no specific news.
- [By Dan Caplinger]
Online travel websites have seen their capabilities improve dramatically in the past decade, and that’s made competition among the industry’s leading players extremely fierce. Trivago (NASDAQ:TRVG) has fought to strengthen its own platform and to let potential customers know the advantages that it offers. Yet that hasn’t made it any easier for the company to work its way through difficult situations and find the best way to communicate its benefits to travelers.
- [By Jeremy Bowman]
Shares of Tripadvisor Inc (NASDAQ:TRIP) were heading lower today, falling in sympathy with Trivago (NASDAQ:TRVG)after shares of the hotel-booking platform crashed 24% when the company recorded a decline in first-quarter revenue and cut its guidance for the year. Though there was no direct news out on Tripadvisor today, shares of the travel-recommendation service nonetheless finished down 8.5% today as it is subject to many of the same business trends as Trivago in the online travel industry.
Top 5 Value Stocks To Own Right Now: Park-Ohio Holdings Corp.(PKOH)
Advisors’ Opinion:
- [By Max Byerly]
Park-Ohio Holdings Corp. (NASDAQ:PKOH) has earned an average rating of “Hold” from the six research firms that are covering the firm, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, three have given a hold recommendation and one has assigned a buy recommendation to the company. The average 12-month price target among brokers that have issued a report on the stock in the last year is $45.00.
- [By Logan Wallace]
Get a free copy of the Zacks research report on Park-Ohio (PKOH)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Ethan Ryder]
TheStreet upgraded shares of Park-Ohio (NASDAQ:PKOH) from a c+ rating to a b- rating in a report issued on Friday.
PKOH has been the topic of several other reports. Zacks Investment Research upgraded Park-Ohio from a hold rating to a buy rating and set a $45.00 price target on the stock in a research report on Friday, May 18th. BidaskClub upgraded Park-Ohio from a strong sell rating to a sell rating in a research report on Thursday, May 17th. Finally, ValuEngine lowered Park-Ohio from a strong-buy rating to a buy rating in a research report on Monday, April 2nd. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and one has given a buy rating to the company. The stock has an average rating of Hold and an average price target of $41.00.
